Tandem Diabetes Care Inc share price logo

Tandem Diabetes Care Inc

NASDAQ: TNDM

Small Cap

$19.43

-0.44

(-2.19%)

as on

Tandem Diabetes Care Inc Stock Performance

as on May 6, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $18.91
    $19.92
    downward going graph

    2.68%

    Downside

    2.52%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $9.98
    $29.65
    downward going graph

    48.64%

    Downside

    52.60%

    Upside

    downward going graph

Tandem Diabetes Care Inc share price movements today

Previous Close
$19.87
Open
$19.90
Volume
1.2M
Day's Low - High
$18.91 - $19.92
52 Week Low - High
$9.98 - $29.65

Tandem Diabetes Care Inc Historical Returns

1 Month Return
+ 1.3 %
3 Month Return
+ 1.3 %
1 Year Return
-8.91 %
3 Year Return
-44.61 %
5 Year Return
-77.47 %

Tandem Diabetes Care Inc Stock Fundamentals & Key Indicators

Check Tandem Diabetes Care Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.3B

EPS (TTM)

-0.8011

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.37%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-60.5M

Revenue (TTM)

1.0B

Profit Margin

-20.17%

Return On Equity TTM

-97.89%

Tandem Diabetes Care Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tandem Diabetes Care Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Tandem Diabetes Care Inc image
Tandem Diabetes Care Inc
BUY$1.3B-77.47%NA-20.17%
Boston Scientific Corp image
Boston Scientific Corp
BUY$83.2B30.07%23.4217.29%
Stryker Corporation image
Stryker Corporation
BUY$113.1B16.18%35.1113.21%
Edwards Lifesciences Corp image
Edwards Lifesciences Corp
BUY$47.8B-9.63%44.8217.39%
Medtronic PLC image
Medtronic PLC
BUY$99.9B-38.89%21.7313.00%
See all

Stock Returns calculator for Tandem Diabetes Care Inc Stock including INR - Dollar returns

The Tandem Diabetes Care Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Tandem Diabetes Care Inc investment value today

Current value as on today

₹1,02,288

Returns

₹2,288

(+2.29%)

Returns from Tandem Diabetes Care Inc Stock

-₹8,865 (-8.86%)

Dollar Impact

₹11,153 (+11.15%)

Analyst Recommendation on Tandem Diabetes Care Inc Stock

Based on 23 analysts

BUY

65.22%

Buy

30.43%

Hold

4.35%

Sell

Based on 23 analysts, 65.22% of analysts recommend a 'BUY' rating for Tandem Diabetes Care Inc. Average target price of $31.19

Tandem Diabetes Care Inc Share Price Target

Get share price movements and forecasts by analysts on Tandem Diabetes Care Inc.

What analysts predicted

37.7%UPSIDE

Target Price

$31.19

Current Price

$19.43

Analyzed by

23 Analysts

Target

$31.19

Tandem Diabetes Care Inc target price $31.19, a slight upside of 37.7% compared to current price of $19.43. According to 23 analysts rating.

Indian Investors' Interest in Tandem Diabetes Care Inc Stock

Search interest for Tandem Diabetes Care Inc Stock has decreased by -43% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-43% versus previous 30 day period

Tandem Diabetes Care Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
185
196
191
221
363
282
234
240
249
290
Gross Profit
89
93
94
112
124
157
118
125
134
167
Operating Income
-31
-35
-41
-30
-26
0
-120
-51
-20
8
EBITDA
-22
-25
-34
-23
-16
6
-116
-50
-18
11
Interest Expense
4
1
1
1
1
1
1
2
2
2
Depreciation
4
4
4
4
4
4
4
4
4
4
Income Before Tax
-30
-31
-39
-29
-22
0
-122
-57
-25
4
Income Tax Expense
2
-1
3
1
0
0
8
-5
-3
5
Net Income
-32
-30
-42
-30
-23
0
-130
-52
-21
0
Net Profit Margin
-17.76%
-15.25%
-22.29%
-13.89%
-6.40%
0.27%
-55.69%
-21.77%
-8.49%
-0.20%

Tandem Diabetes Care Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
84
107
183
362
498
702
801
747
940
1,014
Gross Profit
23
44
89
194
260
376
412
367
489
530
Operating Income
-78
-62
-44
-16
-7
22
-92
-233
-99
-78
EBITDA
-72
-56
-38
-10
2
34
-74
-196
-99
-174
Interest Expense
5
11
7
0
12
6
6
9
7
7
Depreciation
-
6
5
6
10
13
14
15
16
17
Income Before Tax
-83
-73
-122
-24
-36
15
-92
-220
-91
-200
Income Tax Expense
0
0
0
0
-1
0
1
2
4
4
Net Income
-83
-73
-122
-24
-34
15
-94
-222
-96
-204
Net Profit Margin
-99.05%
-67.87%
-66.68%
-6.83%
-6.89%
2.21%
-11.81%
-29.77%
-10.21%
-20.17%

Tandem Diabetes Care Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-30
-42
-30
-23
0
-130
-52
-21
0
Operating Cash Flow
-7
-7
-5
26
10
-18
-9
8
9
Investing Cash Flow
-16
-5
-3
-19
5
9
58
20
-14
Financing Cash Flow
2
13
-3
-4
2
-4
-39
-1
2
Change in Cash
-20
0
-11
1
20
-15
10
27
-1

Tandem Diabetes Care Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-73
-122
-24
-34
15
-94
-222
-96
-204
Operating Cash Flow
-66
-8
41
24
111
50
-31
24
-9
Investing Cash Flow
2
-90
-56
-296
-186
33
-85
-23
72
Financing Cash Flow
32
117
24
314
51
16
4
8
-43
Change in Cash
-30
18
9
43
-23
101
-113
10
21

Global Institutional Holdings in Tandem Diabetes Care Inc

Funds
Holdings
Sessa Capital, L.P
7.3%
Sessa Capital IM LP
7.4%
ArrowMark Colorado Holdings, LLC (ArrowMark Partners)
4.22%
Jacobs Levy Equity Management, Inc.
2.41%
Baillie Gifford & Co Limited.
1.67%
See all

Tandem Diabetes Care Inc News & Key Events

  • img

    Today's Timeline - 23 February

    Mon, 07:49 PM

    -

    Brown Capital Management sold Tandem Diabetes from its portfolio due to disappointing revenue growth and profitability concerns.

    Mon, 08:02 PM

    -

    Lake Street upgraded Tandem Diabetes to Buy with a price target of $50, citing improved growth and margins.

Insights on Tandem Diabetes Care Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, -130.55M → -589.0K (in $), with an average increase of 1263.4% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 234.42M → 290.38M (in $), with an average increase of 6.7% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, TNDM stock has moved up by 6.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Tandem Diabetes Care, Inc. has experienced a drawdown of -44.6%, however Boston Scientific Corp. resisted the overall trend and outperformed by 38.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp. has given 10.7% return, outperforming this stock by 19.6%

About Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
OrganisationTandem Diabetes Care Inc
Headquarters12400 High Bluff Drive, San Diego, CA, United States, 92130
IndustryMedical Devices
CEOMr. John F. Sheridan
E-voting on sharesClick here to vote

Key Management of Tandem Diabetes Care Inc

Name

Title

Mr. John F. Sheridan

President, CEO & Director

Ms. Shannon M. Hansen J.D.

Executive VP, Chief Legal, Privacy & Compliance Officer and Secretary

Mr. Mark Novara

Executive VP & Chief Commercial Officer

Mr. Tom Fox

Executive VP & Chief Human Resources Officer

Dr. Jordan Pinsker M.D.

Chief Medical Officer

Ms. Leigh A. Vosseller

Executive VP, CFO & Treasurer

Ms. Elizabeth Anne Gasser

Executive VP and Chief Strategy & Product Officer

Mr. Jean-Claude E. Kyrillos

Executive VP & COO

Mr. Rick A. Carpenter

Executive VP & CTO

Ms. Susan M. Morrison

Executive VP & Chief Administrative Officer

FAQs

What is Tandem Diabetes Care Inc share price today?

Tandem Diabetes Care Inc share price today is $19.43 as on at the close of the market. Tandem Diabetes Care Inc share today touched a day high of $19.92 and a low of $18.91.

What is the 52 week high and 52 week low for Tandem Diabetes Care Inc share?

Tandem Diabetes Care Inc share touched a 52 week high of $29.65 on and a 52 week low of $9.98 on . Tandem Diabetes Care Inc stock price today i.e. is closed at $19.43,which is 34.47% down from its 52 week high and 94.69% up from its 52 week low.

What is Tandem Diabetes Care Inc's market capitalisation today?

Tandem Diabetes Care Inc market capitalisation is $0.00T as on .

How to invest in Tandem Diabetes Care Inc Stock (TNDM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Tandem Diabetes Care Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tandem Diabetes Care Inc Shares that will get you 0.0772 shares as per Tandem Diabetes Care Inc share price of $19.43 per share as on May 6, 2026 at 1:29 am IST.

What is the minimum amount required to buy Tandem Diabetes Care Inc Stock (TNDM) from India?

Indian investors can start investing in Tandem Diabetes Care Inc (TNDM) shares with as little as ₹94.61 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.10 in Tandem Diabetes Care Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Tandem Diabetes Care Inc share’s latest price of $19.43 as on May 6, 2026 at 1:29 am IST, you will get 0.5147 shares of Tandem Diabetes Care Inc. Learn more about fractional shares .

What are the returns that Tandem Diabetes Care Inc has given to Indian investors in the last 5 years?

Tandem Diabetes Care Inc stock has given -77.47% share price returns and 28.83% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?